ALK-Abelló A/S
ALK-B
Rank in Stocks
#2403
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Share Price
$36.42
Last synced: 2026-10-21
Market Cap
$8.08B
Change (1 day)
-3.54%
Change (1 year)
9.56%
Country
DK
Trade ALK-Abelló A/S (ALK-B)
Category
Healthcare
Stock price history for ALK-Abelló A/S (ALK-B)
Highest end of day price: $35.28 on 2026-10-01
Lowest end of day price: $2.20 on 2000-03-01
Lowest end of day price: $2.20 on 2000-03-01
Stock price history of ALK-Abelló A/S from 2000 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 0.06% |
| 2025 | 59.11% |
| 2024 | 58.09% |
| 2023 | 1.18% |
| 2022 | -44.26% |
| 2021 | 35.05% |
| 2020 | 52.05% |
| 2019 | 69.02% |
| 2018 | 21.48% |
| 2017 | -6.26% |
| 2016 | 1.94% |
| 2015 | 12.10% |
| 2014 | 0.42% |
| 2013 | 62.90% |
| 2012 | 20.99% |
| 2011 | -3.28% |
| 2010 | -29.09% |
| 2009 | -18.50% |
| 2008 | -23.13% |
| 2007 | -41.96% |
| 2006 | 116.04% |
| 2005 | -9.24% |
| 2004 | 116.11% |
| 2003 | 47.42% |
| 2002 | 45.17% |
| 2001 | -23.57% |
| 2000 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.50 | -4.01% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
